Video
Bruce Burnett, Swansea University, Swansea, UK, highlights the important considerations when choosing cancer clinical trial endpoints. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.